Searchable abstracts of presentations at key conferences in endocrinology

ea0029oc11.2 | Thyroid Clinical 2 | ICEECE2012

Subclinical thyroid disease and risk of new-onset atrial fibrillation

Selmer C. , Olesen J. , Lindhardsen J. , Olsen A. , Madsen J. , Schmidt U. , Faber J. , Hansen P. , Pedersen O. , Hansen M. , Torp-Pedersen C. , Gislason G.

Background: It is still uncertain if subclinical thyroid disease or ‘high-normal’ thyroid function are risk-factors for atrial fibrillation (AF).Objectives: To examine the risk of AF in relation to thyroid function.Methods: Patients consulting their general practitioner from 2000–2009 in Copenhagen, Denmark, who underwent thyroid blood tests, were identified by individual-level linkage of nationwide registries. Patie...

ea0063gp136 | Obesity | ECE2019

Administration of a growth hormone bolus down-regulates gene-expression of the g0/g1 switch gene 2 (g0s2) in subcutaneous adipose tissue in healthy, obese men: a randomized, placebo-controlled, cross-over study

Hjelholt Astrid , Jessen Niels , Arlien-Soborg Mai Christiansen , Pedersen Steen Bonlokke , Jorgensen Jenso Otto Lunde

Background: Growth hormone (GH) potently stimulates lipolysis, and after GH exposure, levels of serum free fatty acids (FFAs) increase in a distinct temporal pattern characterized by a 1-hour lag phase and a peak after 3 hours followed by a gradual return to baseline. This effect predominantly operates during fasting and promotes utilization of lipids from adipose tissue (AT) at the expense of glucose and protein. Prolonged fasting also downregulates the expression of the G0/G...

ea0049gp190 | Pituitary & endocrine Tumours | ECE2017

Safety of long-term growth hormone (GH) treatment in adults with GH deficiency (GHD): an analysis from the NordiNet® International Outcome Study

Jorgensen Jens Otto , Popovic-Brkic Vera , Pournara Effie , Pedersen Birgitte , Chudecka Anita , Strasburger Christian

Background: Long-term safety data (1998 to mid-2016) are reported for adult patients with GHD treated with GH (Norditropin® (somatropin), Novo Nordisk) as prescribed by treating physicians in the real-life clinical setting and enrolled in NordiNet® International Outcome Study (IOS) (NCT00960128), a non-interventional, multicentre study.Objective and hypotheses: To describe and report safety data and incidence rates (IRs) (...

ea0043oc9 | Cardiovascular Outcome Studies | WCTD2016

Years of Life Gained by Multifactorial Intervention in Patients with Type 2 Diabetes and Microalbuminuria – 21 Years Follow-Up on the Steno-2 Study

Ollgaard Jens , Gaede Peter , Carstensen Bendix , Rossing Peter , Lund-Andersen Henrik , Parving Hans-Henrik , Pedersen Oluf

Aims: To study the potential long-term impact of a 7.8 years intensified, multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria in terms of gained years of life and years free from incident cardiovascular disease.Methods: The original intervention (mean treatment duration 7.8 years) involved 160 patients with type 2 diabetes and microalbuminuria that were randomly assigned to either conventional therapy or intensified...

ea0041ep704 | Growth hormone IGF axis - basic | ECE2016

Concomitant medication in growth hormone (GH)-treated patients with adult GH deficiency (AGHD): an analysis from NordiNet® International Outcome Study (IOS)

Hoybye Charlotte , Pournara Effie , Pedersen Birgitte Tonnes , Jorgensen Jens Otto Lunde

Introduction: Patients with AGHD receiving GH often have comorbidities requiring concomitant treatment. We evaluated patterns of concomitant medication use relative to GH therapy initiation in patients with AGHD.Methods: Patients with AGHD with data on concomitant medications enrolled in NordiNet® IOS (NCT00960128), an international, non-interventional study, receiving GH (Norditropin®, Novo Nordisk A/S, Denmark) therapy w...

ea0037gp.09.04 | Nuclear receptors and signalling | ECE2015

Characterisation of insulin and β2-adrenergic receptor heteromers: experimental and bioinformatics approach

Mandic Maja , Glisic Sanja , Pedersen Christina , Veljkovic Nevena , Nohr Jane , Vrecl Milka

Evidences for a functional link between insulin receptor (IR) and β2-adrenergic receptor (β2AR) exist in the mouse heart and in retina and are correlated with the cardiovascular dysfunction under insulin-resistant states1 and a diabetic retinopathy phenotype2. In our recent study we showed that i) IR coexpression reduced β2AR surface expression and accelerated its internalization, ii) provided evidence for d...

ea0037ep667 | Pituitary: basic and neuroendocrinology | ECE2015

GH therapy has a beneficial effect on HbA1c levels in adult patients with GH deficiency: a report from the NordiNet® International Outcome Study

Weber Matthias , Pedersen Birgitte Tonnes , Pournara Effie , Christiansen Jens Sandahl , Hoybye Charlotte

Introduction: The clinical significance of the impact of GH on glucose homeostasis in adults with GH deficiency (GHD) remains unclear. We report the impact of 4 years of continuous GH therapy on HbA1c and progression to diabetes.Methods: Data were analysed from patients with adult-onset GHD (>20 years old) enrolled in NordiNet® International Outcome Study (IOS) (NCT00960128), an observational study, and treated with GH (Norditropin<su...

ea0035p671 | Growth hormone IGF axis basic | ECE2014

Epigenetic regulation of GH target genes and its relation to in vivo GH signaling in skeletal muscle of adult human males: a pilot study

Pedersen Morten H , Vestergaard Poul F , Switnicki Michal , Jessen Niels , Jorgensen Jens O L

Background: GH secretion and action change with age in adult human subjects, and this play an important role in substrate metabolism in aging subjects. Targeted disruption of the GH receptor in mice extends longevity, and this is associated with decreased expression of apoptosis-related genes including caspase-9 (CASP9) in skeletal muscle.Aim: To study DNA methylation of putative GH target genes in skeletal muscle of adult male subjects in relation to bo...

ea0032p614 | Female reproduction | ECE2013

Mitochondrial function of pregnant women with subclinical hypothyroidism and gestational hypertension

Feldthusen Anne-Dorthe , Larsen Jacob , Pedersen Palle Lyngsie , Kristensen Tina Toft , Anthonsen Stine , Kvetny Jan

Introduction: Subclinical hypothyroidism (subhypo) is linked to gestational hypertension (gestHT) and preeclampsia. Thyroid hormones have major influence on mitochondrial activity and the mitochondrial membrane potential (MMP) reflects the functional status of the mitochondria.Aim: The aim was to estimate whether mitochondrial function is impaired in pregnant women with or without gestHT.Methods: We included third trimester pregnan...

ea0032p622 | Growth hormome IGF axis – basic | ECE2013

A comparison of the in vitro production of IGFs, IGFBP-4 and PAPP-A in cultures of visceral and subcutaneous adipose tissue fragments from obese subjects

Frystyk Jan , Gude Mette Faurholdt , Hjortebjerg Rikke , Oxvig Claus , Pedersen Steen Bonlokke

Background: Visceral adipose tissue (VAT) is less insulin sensitive and more harmful than subcutaneous adipose tissue (SAT). In adipocytes, IGF1 receptor signaling has been linked to insulin resistance, but it is unknown whether VAT and SAT also differ in production of IGFs. Therefore, we compared IGFs, IGFBP-4 and PAPP-A production in cultured fragments of VAT and SAT from obese subjects.Methods: VAT and SAT was collected perioperatively during elective...